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Key points
●● The Global Lung Function Initiative (GLI) Network was established as a result of international 
collaboration, and altruism between researchers, clinicians and industry partners. The ongoing 
success of the GLI relies on network members continuing to work together to further improve how 
lung function is reported and interpreted across all age groups around the world.
●● The GLI Network has produced standardised lung function reference values for spirometry and gas 
transfer tests.
●● GLI reference equations should be adopted immediately for spirometry and gas transfer by 
clinicians and physiologists worldwide.
●● The recently established GLI data repository will allow ongoing development and evaluation of 
reference values, and will offer opportunities for novel research.
Educational aims
●● To highlight the advances made by the GLI Network during the past 5 years.
●● To highlight the importance of using GLI reference values for routine lung function testing 
(e.g. spirometry and gas transfer tests).
●● To discuss the challenges that remain for developing and improving reference values for lung 
function tests.
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The problem
Even when using the highest standards of quality 
and technical ingenuity, results from lung function 
tests can only be clinically valid if interpreted using 
robust, relevant and reliable reference values. 
Reference equations are widely available for a wide 
range of populations and even for subpopulations 
within countries. In fact, there are >400 published 
equations for spirometry alone. Consequently, 
default values set by the manufacturers may 
be adopted, irrespective of whether they are 
appropriate for the ethnic or age group of the 
subject being tested. Differences between 
equations arise from factors such as how healthy 
subjects were selected (with respect to exclusion 
criteria, age range, ethnicity and sex), the number of 
subjects included (sample size), equipment, testing 
protocols, quality control and, very importantly, the 
statistical approach used to derive the equations 
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[2–5]. These differences can have a major effect 
on how lung function results are interpreted, with 
results from the same subject being abnormal 
using one equation while falling within the normal 
range in another [2, 6, 7]. Previously, the use of the 
Third National Health and Nutrition Examination 
Survey (NHANES III) equations in the USA [8] 
and the European Community for Steel and Coal 
(ECSC) equations in Europe [9] were recommended. 
Although very robust, the NHANES III equations 
only span the age range 8–80 years, and are limited 
to Caucasian, African American and Hispanic 
populations, whereas the ECSC reference equations 
were derived from white European adult males 
working in coal mines and steel works, with values 
for female adults approximated as 80% of that for 
a male of similar age and height.
One of the long-standing problems with lung 
function reference equations for has been the lack 
of a single reference source to seamlessly monitor 
patients from childhood into old age. Historically, 
due both to the difficulty in recruiting populations 
across the entire age range and in modelling such 
data to take into account the changing relationship 
between lung size, age and height during the life 
span, separate equations have been developed for 
children and adults. Furthermore, it is only during 
the last decade that reliable spirometry data have 
become available in preschool children (3–6 years) 
[10]. This, in turn, led to the “stitching” together 
of paediatric and adult equation, which inevitably 
led to discontinuities in the interpretation of results 
[6]. The rapid growth observed during childhood 
meant that many paediatric equations relied on 
height alone, the omission of age leading to bias 
both during the preschool years and during puberty 
[11]. A key barrier to creating an “all-age” equation 
was the limited statistical methodology available at 
the time. For many decades, reference equations 
were derived using simple linear regression 
technique to describe the relationship between 
lung function outcomes and age and/or height, 
which made it challenging to describe lung function 
accurately in both children and adults using the 
same equations. More recently, the availability of 
more flexible methodologies has allowed modelling 
of complex non-linear relationships across a wide 
age spectrum.
The solution
In 2008, a group of clinicians, physiologists and 
researchers was convened by Xaver Baur (Germany) 
at the European Respiratory Society (ERS) Annual 
Congress in Berlin, Germany, to discuss the problem 
and to propose solutions. The ideal solution would 
have been to conduct a multinational population 
study, since this would allow standardisation of 
population sampling, equipment, protocols and 
quality control. However, the logistic constraints of 
recruiting thousands of individuals, many of whom 
would have had to be excluded due to respiratory 
disease or smoking history, together with the 
realisation that securing funding for a multimillion-
dollar project during a global financial recession was 
highly unlikely, meant that alternative approaches 
needed to be explored.
One such alternative was to collate existing data 
sources, as originally suggested by Philip Quanjer 
(the Netherlands) in 1995. Quanjer et al. [12] 
demonstrated that data from numerous studies 
could be successfully combined to create a single, 
more robust reference equation. At that time, he 
suggested that “There is potentially much to be 
gained from starting an international database to 
this end, to which researchers who have performed 
studies which comply with international standards 
could submit their cross-sectional and longitudinal 
data” [12].
The feasibility of such an approach had been 
explored just prior to the 2008 ERS Annual 
Congress meeting, in that a multinational project, 
led by Janet Stocks and Sanja Stanojevic (UK). The 
Asthma UK Growth Charts for Spirometry project 
had successfully pooled existing normative data 
to produce the first sex-specific all-age reference 
equations for spirometry, which spanned 4–80 years 
of age [13]. These were subsequently extended 
down to 3 years, after collating available reference 
data from young children 3–7 years of age [11]. A key 
feature of this study was that the three-dimensional 
nature of the relationship between height, age and 
lung function, and the complex growth patterns 
observed during puberty were modelled seamlessly 
to produce a single all-age equation, using a novel 
approach developed by Tim Cole (UK) [14]. While 
the all-age Asthma UK spirometry growth charts 
provided much needed proof of concept for this 
methodological approach, they were only applicable 
to white subjects of European descent, leaving 
much still to be done if improved interpretation of 
lung function, both worldwide and in increasingly 
multiethnic populations, was to be achieved.
Development of the Global 
Lung Function Initiative 
Network
The serendipitous meeting of individuals from a 
range of respiratory medicine disciplines from 
around the world in 2008, just at the time when 
more robust statistical methods for analysing lung 
function results across all ages had been developed, 
was the catalyst for establishing the Global Lung 
Function Initiative (GLI) Network. Four chairs were 
selected to represent a range of disciplines and 
regions around the world (Janet Stocks, Xaver Baur, 
Bruce Culver (USA) and Graham Hall (Australia)), 
together with an analytical team (Philip Quanjer, 
Sanja Stanojevic, Tim Cole and Janet Stocks). The 
group proposed an ERS Task Force that aimed to 
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pool and collate as much of the existing available 
spirometry data from heathy individuals around 
the world to derive all-age, multiethnic reference 
equations. ERS Task Force status for the GLI was 
granted in April 2010, and although the American 
Thoracic Society (ATS) was unable to fund any 
new projects that year, it was actively involved in 
supporting the initiative.
As the result of established collaborations 
with researchers worldwide since the 1990s, 
Philip Quanjer had already accumulated a library 
of anonymised normative spirometry data from 
>30 000 healthy subjects. Gaining permission from 
lead investigators to use these data for the GLI gave 
the project a vital head start. Further requests via 
respiratory societies and collaborative networks 
as well as to lead investigators of published 
papers, resulted in >160 000 sets of anonymised 
spirometry data from healthy individuals being 
submitted. The project received overwhelming 
support and enthusiasm across multiple 
respiratory disciplines.
The GLI Network was largely based on 
collaboration, altruism and a common goal: to 
improve how lung function is interpreted. The 
network grew quickly, with >400 members 
from around the world expressing interest and 
participating in workshops that were held at 
international conferences such as those of the 
ERS and ATS. Importantly, everyone involved in 
the GLI contributed time and effort on an entirely 
voluntary basis, an essential component given that 
the entire Task Force budget only facilitated travel 
and meetings between Task Force Chairs.
A unique aspect of the GLI Network was 
the inclusion of manufacturers of pulmonary 
function test equipment; while manufacturers 
did not provide any funding to the GLI Network, 
by attending the open meetings, manufacturers 
were able to express the needs of the broader 
respiratory community, to highlight the challenges 
of updating and changing reference equations from 
a practical perspective, and provide invaluable 
insight into the educational materials that would 
be needed to educate laboratory staff, patients and 
clinicians when switching to the new equations. 
These relationships were pivotal to the successful 
dissemination and rapid implementation of the 
reference equations across spirometry devices as 
soon as the equations were published in 2012.
The formation of the GLI Network, together 
with a rich data resource, and the availability of 
novel statistical methodology provided, for the first 
time, an opportunity to develop a standardised and 
unified global approach to interpreting lung function 
results across all ages that were applicable across 
many different ethnic groups. With such limited 
funding, the success of the GLI would never have 
been possible without the dedication, perseverance 
and ingenuity of Philip Quanjer. Retired at the time, 
Prof. Quanjer dedicated almost 3 years of around-
the-clock efforts to collate and analyse the data, and 
to maintain the GLI website, until the latter function 
was transferred to the ERS in 2015.
Impact of the GLI spirometry 
reference equations
The ERS GLI Spirometry Task Force derived 
continuous prediction equations and their lower 
limits of normal (LLNs) for key spirometric indices 
[15]. The GLI Network shared over >160 000 data 
points from 72 centres in 33 countries. Some 
data were eliminated because they could not be 
used (mostly missing ethnic group data and some 
outliers), which left 97 759 records of healthy 
nonsmokers (55.3% females) aged 2.5–95 years. 
Reference equations were derived for healthy 
individuals aged 3–95 years for a number of ethnic 
groups including Caucasians (i.e. white subjects of 
European descent, n=57 395), African Americans 
(n=3545), and North (n=4992) and South East 
Asians (n=8255), where North Asian refers to Korea 
and China north of the Huaihe River and Qinling 
Mountains, and South East Asian refers to Thailand, 
Taiwan and China (including Hong Kong) south of 
the Huaihe River and Qinling Mountains. In addition, 
since many individuals were either not represented 
by these four groups or were of mixed ethnic origin, 
a composite equation was derived as the average 
of available data to facilitate interpretation in such 
individuals until a more appropriate solution is 
developed with appropriate data. Spirometric values 
including forced expiratory volume in 1 s (FEV1) and 
forced vital capacity (FVC) differed proportionally 
between ethnic groups from that in Caucasians, 
such that FEV1/FVC remained virtually independent 
of ethnic group (figure 1).
The GLI-2012 reference equations currently 
provide the most reliable spirometric prediction 
equations for the 3–95-year age range and 
include appropriate age-dependent LLNs. The 
GLI equations have been endorsed by all major 
international respiratory societies and adopted as 
the recommended reference equation by many 
national respiratory societies.
Beyond spirometry
Since full interpretation of lung function often 
requires results from more than one lung function 
test, there was a unanimous decision to expand 
the GLI to include reference equations for the 
transfer factor of the lung for carbon monoxide 
(TLCO) (also known as the diffusing capacity of the 
lung for carbon monoxide (DLCO)) and static lung 
volumes. In 2013, the GLI TLCO Task Force, again 
supported by the ERS, was initiated. Over a period 
of 2 years, 12 660 TLCO measurements in healthy 
individuals were collected from 19 centres in 14 
countries. As a result of methodological differences 
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in equipment settings and study populations, TLCO 
had to be harmonised prior to collation. All data 
were uncorrected for haemoglobin concentration, 
but adjusted for partial pressure of oxygen, gas 
concentration and anatomic dead space volume.
Reference values for Caucasians aged 4–80 years 
were derived for TLCO, carbon monoxide transfer 
coefficient and alveolar volume (figure 2) [17]. A 
major limitation of these new TLCO equations is that 
they are limited to Caucasian subjects. Only 15% 
of the data collected were from non-Caucasians, 
which meant it was not possible to investigate 
ethnic differences in outcomes. Fortunately, FEV1 
data submitted as part of the TLCO dataset, and 
largely based on individuals who were not part of the 
original GLI spirometry dataset, had good fit overall 
with the GLI spirometry equations. This supports 
the use of the GLI spirometry and TLCO reference 
equations together, even though they are based 
on different populations. The GLI TLCO equations 
have been published in the European Respiratory 
Journal [17].
In 2016, the GLI Static Lung Volumes Task Force 
was established, and is now well underway. Since 
static lung volumes can be measured with a variety 
of techniques (single or multiple breath, quiet or 
forced rebreathing, nitrogen or helium dilution, 
multiple indicator gases, body plethysmography), 
data are being collected separately for each 
technique and will be investigated for agreement.
Beyond predicted values
Beyond providing standardised reference equations, 
the GLI Network has reignited debate and discussion 
around how lung function is interpreted. Whereas 
in clinical chemistry, classification of normal 
and abnormal test results is based on the 95% 
reference interval, it has become an ingrained 
habit in respiratory medicine to express measured 
values as “per cent of predicted”. This tradition 
probably arose from a recommendation by Bates 
and Christie [18]: “a useful gen eral rule is that a 
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Figure 1 Predicted values for a, b) FEV1, c, d) FVC and e, f) FEV1/FVC by sex and ethnic group. a, c, e) Males and b, d, 
f) females. Graphs were generated using mean height for age in Caucasians to illustrate proportional differences between 
ethnic groups of the same height and age; in practice, differences in height for age further affect predicted values. The rise 
and fall in FEV1/FVC around adolescence is due to differential changes in FEV1 and FVC. Reproduced from [15].
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deviation of 20% from the predicted normal value 
probably is significant”. This suggested that 80% 
of predicted was the LLN. Although this rule of 
thumb was uncritically adopted, it is only valid if the 
scatter around the predicted value has a standard 
deviation approximating 10% and is proportional 
to the mean predicted value, neither of which is 
the case, as shown in multiple studies [19–21]. 
The methodology used to derive the LLN for all GLI 
equations takes into account that the spread of 
values around the predicted values is not uniform, 
and that the LLN is age and outcome dependent. 
Using an appropriate LLN is essential in order to 
differentiate between health and disease accurately 
across the entire life span.
Geriatric considerations
Populations worldwide are rapidly ageing [22]. By 
2050, the World Health Organization estimates that 
400 million people will be aged ≥80 years [22]. The 
ageing shift is accompanied by substantial clinical 
challenges, including multimorbidity, polypharmacy 
and a highly sedentary state [23, 24]. It is therefore 
not surprising that respiratory symptoms, such as 
dyspnoea, chronic bronchitis and wheezing, are also 
highly prevalent in older persons and are likely to 
be multifactorial in origin [25, 26].
Accordingly, among older persons with 
respiratory symptoms, high diagnostic accuracy 
is a necessity when attributing the underlying 
mechanism to a respiratory impairment [23–27]. 
Because it rigorously accounts for age-related 
changes in lung function, the GLI approach 
represents a major step forward in establishing an 
age-appropriate and clinically meaningful definition 
of a respiratory impairment [13, 15, 28]. In addition, 
by minimising the misidentification of normal-for-
age lung function as a respiratory impairment [29], 
the GLI approach may avoid the use of inappropriate 
and potentially harmful respiratory medications in 
older persons, as well as delays in considering other 
diagnoses among older persons with respiratory 
symptoms [23–27].
Nevertheless, there remain some limitations 
regarding the use of GLI reference equations in 
older persons. Specifically, as acknowledged in the 
2012 GLI report [15], increased representation of 
persons aged >75 years in the reference population 
is needed to further improve diagnostic accuracy. 
Beyond 80 years of age, there is the issue of 
survival bias, and there is limited information 
available regarding the generalisability of the 
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Figure 2 a) Predicted TLCO in i) 4859 males and ii) 4851 females), b) alveolar volume (VA) (standard temperature and 
pressure, dry) in i) 4793 males and ii) 4837 females) and c) carbon monoxide transfer coefficient (KCO) in i) 4793 males 
and ii) 4837 females. The solid line represents the predicted values for age (assuming an average height at each) and the 
dashed lines represent 95% confidence limits. Prediction equations are overlaid on observed values. The average height 
used in children was the 50th height-for-age centile from the US Centers for Disease Control and Prevention growth charts 
[16] whereas in adults, the average height observed in the study population was used (172 cm in males and 162 cm in 
females). Reproduced from [17].
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GLI equations in this population [30]. Therefore, 
caution is required when interpreting lung function 
in older individuals, and the need for more data in 
older subjects to develop updated age-appropriate 
criteria regarding the adequacy of test performance 
and to evaluate alternative measures of lung 
function. These improvements may broaden the 
generalisability of respiratory test results in geriatric 
practice.
Challenges
The GLI Network is not without its challenges. 
Despite its name, the GLI lacks data from large 
populations, namely those on the African continent, 
South Asia and India, and Latin America. The 
TLCO equations are only available for Caucasians. 
Although spirometry reference equations were 
derived for the Asian population, studies have 
shown both cohort and migration effects on lung 
function in these populations [31, 32]. Several 
efforts have been made to collect and summarise 
data in these populations [31, 33, 34], and while 
these studies provide critical information regarding 
the generalisability of GLI in these populations, 
the conclusions have consistently been that 
prospective, high-quality data are needed in these 
populations, and that consideration of the effects 
of migration, both within the region and to western 
countries, is necessary to provide comprehensive 
recommendations for improved interpretation of 
results.
Although many regional respiratory societies 
have endorsed the GLI and individual laboratories 
have implemented the GLI spirometry equations, 
there are also many who have been reluctant to 
do so, often citing “myths” and misconceptions as 
reasons for this inaction [1]. Some argued that they 
cannot implement GLI-2012 because no reference 
values for transfer factor and static lung volumes are 
available, a criticism that is now largely outdated. 
Others argued that the lack of predicted values for 
peak expiratory flow and other flows means that 
they cannot interpret flow–volume curves. These 
myths regarding spirometry interpretation are 
generally now fully debunked in academic circles 
but need to be spread through education to the 
clinical “coalface”
At the time the GLI was established, privacy 
and data sharing rules and regulations were just 
emerging. Since all data were de-identified, there 
were limited logistical and operational hurdles to 
collecting and receiving data between academic 
institutions. This is very much no longer the case 
and, as the GLI Network evolved, so did the need 
for more rigorous data sharing policies and data 
management systems. When the GLI TLCO Task Force 
was established, the infrastructure to collect and 
store the data was also updated. There have been 
several promising open-source projects for enabling 
privacy-sensitive data sharing [35]; however, these 
methods require an investment in infrastructure 
and information technology expertise at all data 
contributing sites. To address the scarcity of 
available technical solutions, the bioinformatics 
group at the Telethon Kids Institute (Kim Carter, 
Australia) built an intuitive, flexible and extensible 
data collection portal, called the Data Portal for 
Research (DPR), using open-source technologies 
(available from https://gitlab.com/kim.carter/dpr). 
Through DPR, it was possible to have contributors 
of data to the GLI sign up to the project online and, 
after approval, be provided access to the secure 
data upload portal. Data from each contributor are 
uploaded using a predefined data and metadata 
spreadsheet template, with all uploaded data 
checked against a defined data dictionary for 
validity (e.g. correct data type, appropriate range 
and missing data characters) before being made 
available for comparison with other uploaded data. 
Predefined analyses are run on each dataset, with 
the ability to compare and analyse all upload data 
across datasets securely through an intuitive and 
interactive graphical interface.
The future of the GLI 
Network
The GLI Network was formally established 
as an ERS Clinical Research Collaboration in 
2016, and aims to develop a live repository of 
normative lung function data housed by the ERS. 
All current data contributors will be invited to 
give permission for data to be transferred to the 
repository. New data sharing agreements will be 
Educational questions
1. The errors of using a “fixed ratio”: when using a fixed ratio of FEV1/FVC, 
which of the following are correct?
a. Airway obstruction is underestimated in the elderly (>70 years)
b. Airway obstruction is overestimated in the elderly (>70 years)
c. Airway obstruction is underestimated in adolescents
d. Airway obstruction is overestimated in adolescents 
2. The errors of using per cent of predicted: does the FEV1 for a person of 
the same height have the same LLN at ages 25 and 65 years?
a. Yes
b. No 
3. GLI reference equations are now available for which lung function tests?
a. Spirometry
b. Respiratory muscle pressures
c. TLCO
d. Lung volumes
e. Blood gases
f. Peak expiratory flow
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sought, and data will be uploaded and hosted 
through an established infrastructure developed 
by the bioinformatics team at the Telethon Kids 
Institute. Data collection will be ongoing such 
that reference equations can be derived as new 
data become available for groups not previously 
represented. Importantly, the data repository 
has been established to facilitate longitudinal 
data, as well as having the potential to expand to 
include data from various disease groups. The GLI 
data repository will be available for researchers 
to access to answer novel physiological and 
methodological questions.
The GLI Network will also work with the European 
Lung Foundation (ELF) to improve resources for 
patients, educators and clinicians. Dissemination 
of training and education materials about 
interpretation of lung function tests results needs 
to go beyond the pulmonary function laboratory. 
The ELF is therefore developing videos and patient 
resources in multiple languages to help improve 
and standardise interpretation.
Can Breathe readers help?
Any centre that has collected (or is collecting) lung 
function data in healthy individuals anywhere in the 
world should consider contacting the GLI Network. 
Anyone who previously contributed is invited to 
give permission for their data to be included in 
the repository. For more information, visit the GLI 
website: www.lungfunction.org
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